The properties of the different IgG isotypes should be considered in developing therapeutic antibodies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients
Arthritis Research & Therapy Open Access 06 January 2021
-
Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice
Alzheimer's Research & Therapy Open Access 13 January 2020
-
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
Drug Safety Open Access 16 January 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van der Neut Kolfschoten, M. et al. Science 317, 1554–1557 (2007).
Jefferis, R. Expert Opin. Biol. Ther. 7, 1401–1413 (2007).
Carter, P. Nat. Rev. Immunol. 6, 343–357 (2006).
Filpula, D. Biomol. Eng. 24, 201–215 (2007).
van der Zee, J.S. et al. J. Immunol. 137, 3566–3571 (1986).
Schuurman, J. et al. Immunology 97, 693–698 (1999).
Angal, S. Mol. Immunol. 30, 105–108 (1993).
Schuurman, J. et al. Mol. Immunol. 38, 1–8 (2001).
Aalberse, R.C. & Schuurman, J. Immunology 105, 9–19 (2002).
Forrer, K. et al. Anal. Biochem. 334, 81–88 (2004).
Taylor, F.R. et al. Anal. Biochem. 353, 204–208 (2006).
Yoo, E.M. et al. J. Immunol. 170, 3134–3138 (2003).
Lewis, M.J. Mol. Immunol. 45, 818–827 (2007).
Duncan, A. et al. Nature 332, 563–564 (1988).
Suitters, A.J. et al. J. Exp. Med. 179, 849–856 (1994).
Reddy, M.P. et al. J. Immunol. 164, 1925–1933 (2000).
Cole, M.S. et al. J. Immunol. 159, 3613–3621 (1997).
Beevenhouwer, D.O. Infect. Immun. 75, 1424–1435 (2007).
The workshop slides from Patrick G. Swann are available at www.aapspharmaceutica.com/meetings/files/57/swannho.pdf
Weinberg, W.C. et al. Cancer Metastasis Rev. 24, 569–584 (2005).
Dillon, T.M. et al. J. Chromatogr. A. 1053, 299–306 (2004).
Alyanakian, M.-A. et al. Vox Sang. 84, 188–192 (2003).
WHO Review of the notation for the allotypic and related markers of human immunoglobulins. Eur. J. Immunol. 6, 599–601 (1976).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
J.S. works for Abbott Laboratories, a global healhcare company.
Rights and permissions
About this article
Cite this article
Salfeld, J. Isotype selection in antibody engineering. Nat Biotechnol 25, 1369–1372 (2007). https://doi.org/10.1038/nbt1207-1369
Issue Date:
DOI: https://doi.org/10.1038/nbt1207-1369
This article is cited by
-
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients
Arthritis Research & Therapy (2021)
-
Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice
Alzheimer's Research & Therapy (2020)
-
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
Drug Safety (2019)
-
Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis
Nature Communications (2018)
-
The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding
Scientific Reports (2018)
